It might when it isn't able to generate any cash from trading and seems to be relying on one-off working capital release and asset sales to achieve debt reduction.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025